TIGERQ (private company)
See something wrong or missing? Let us know
Offices:Lund
Industry:BiotechHealth services
Business model:B2B
TIGERQ develops a sample-to-analysis solution, a state-of-the-art NGS pipeline, combined with proprietary analysis, for answers of the highest accuracy to all gene editing efficiency questions.
values in USD
Investments 1.15M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to TIGERQ
Name | Criteria | |
---|---|---|
![]() |
AbolerIS Pharma
42%
|
|
![]() |
APIM Therapeutics
42%
|
|
![]() |
AptaTargets
42%
|
|
![]() |
Athera
42%
|
|
![]() |
AttgeNO
42%
|
|
![]() |
Bio-Me
42%
|
|
![]() |
Biograil
42%
|
|
![]() |
Biomes
42%
|
|
![]() |
Biotts
42%
|
|
![]() |
Cebiotex
42%
|
|